GE HealthCare Technologies/$GEHC
1D1W1MYTD1Y5YMAX
Capital at risk
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
- Ticker
- $GEHC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 54,000
- Headquarters
- Chicago, United States
- Website
- www.gehealthcare.com
GEHC Metrics
BasicAdvanced
$29B
14.80
$4.34
0.84
$0.14
0.22%
Price and volume
Market cap
$29B
Beta
0.84
52-week high
$89.77
52-week low
$58.75
Average daily volume
2.8M
Dividend rate
$0.14
Financial strength
Current ratio
1.264
Quick ratio
0.831
Long term debt to equity
0.928
Total debt to equity
0.94
Dividend payout ratio (TTM)
3.22%
Interest coverage (TTM)
7.84%
Profitability
EBITDA (TTM)
3,593
Gross margin (TTM)
39.53%
Net profit margin (TTM)
9.33%
Operating margin (TTM)
14.04%
Effective tax rate (TTM)
22.95%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
5.13%
Return on equity (TTM)
19.38%
Valuation
Price to earnings (TTM)
14.804
Price to revenue (TTM)
1.373
Price to book
2.64
Price to tangible book (TTM)
-4.83
Price to free cash flow (TTM)
18.494
Free cash flow yield (TTM)
5.41%
Free cash flow per share (TTM)
3.474
Dividend yield (TTM)
0.22%
Forward dividend yield
0.22%
Growth
Revenue change (TTM)
6.51%
Earnings per share change (TTM)
-11.06%
3-year revenue growth (CAGR)
3.76%
3-year earnings per share growth (CAGR)
6.24%
3-year dividend per share growth (CAGR)
32.64%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
Analyst projections of the future price of GE HealthCare Technologies stock.
Bulls say / Bears say
The pharmaceutical diagnostics segment recorded a 15.6% year-on-year sales increase in Q2 2026, driven by robust contrast media and radiopharmaceutical demand. (Reuters)
Imaging device revenues grew 7.9% YoY in Q2 2026, reflecting sustained global demand for core diagnostic equipment. (Reuters)
GE HealthCare exceeded Q2 revenue estimates, reporting $5.30 billion against a consensus of $5.26 billion, while maintaining its full-year profit forecast, signaling resilient underlying demand. (Reuters)
Patient Care Solutions sales plunged 13.3% YoY to $675 million in Q2 2026, underscoring persistent operational and supply-chain challenges in the unit. (Reuters)
The company’s adjusted core margin contracted 40 basis points YoY in Q2 2026, pressed by higher costs for memory chips, oil, and freight. (Reuters)
Management is exploring a sale of its Patient Care Solutions segment, highlighting strategic concern over the unit’s underperformance. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 25 Aug 2026.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
Upcoming events
No upcoming events
GEHC News
AllArticlesVideos
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
Reuters2 days ago
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
Business Wire3 weeks ago
GE HealthCare management to present at upcoming investor conference
Business Wire3 weeks ago
Funds containing GEHC
AllEURGBPUSD
Fund name | Fund size | $GEHC weighting |
|---|---|---|
VanEck Morningstar Wide Moat€GMVM | €407M | 2.11% |
VanEck Morningstar Wide Moat£MOGB | £354M | 2.11% |
iShares AI Adopters and Applications€AIAA | €169M | 0.60% |
iShares AI Adopters and Applications£AIAA | £145M | 0.60% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.48% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.